173: Psychedelic Capitalism (w/Psymposia)
The market for psychedelics is projected to grow from $2 billion in 2020 to $10.75 billion by 2027—a growth rate that could outpace the legal US cannabis market. Many high-profile investors and celebrities are entering the space, often under the pretense of funding breakthrough mental health interventions.
But…is that the real concern? Microdosing to help depression, anxiety, addiction, or suicidal ideation are all laudable goals. But is that what’s really happening in the psychedelics space?
Derek is joined by Psymposia co-founder, editor, and producer, Brian Normand; medicine, society, and culture research fellow, Neşe Devenot, PhD; and managing editor and harm reduction advocate, David Nickles. This far-reaching discussion about the history and future of psychedelics touches upon numerous aspects of this burgeoning industry.
Show Notes
Church of Psilomethoxin, Part 1: Sacramental Skepticism. Is the Church in Denial?
Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency
